Galectin Therapeutics Inc GALT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
2.39UNCH (UNCH)
Volume
896
Close
2.39UNCH (UNCH)
Volume
56,796
52 week range
1.28 - 2.48
Loading...
  • Open2.38
  • Day High2.43
  • Day Low2.30
  • Prev Close2.41
  • 52 Week High2.48
  • 52 Week High Date03/25/24
  • 52 Week Low1.28
  • 52 Week Low Date06/26/23

Key Stats

  • Market Cap147.818M
  • Shares Out61.85M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change43.98

KEY STATS

  • Open2.38
  • Day High2.43
  • Day Low2.30
  • Prev Close2.41
  • 52 Week High2.48
  • 52 Week High Date03/25/24
  • 52 Week Low1.28
  • 52 Week Low Date06/26/23
  • Market Cap147.818M
  • Shares Out61.85M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change43.98

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-3.15
  • Fwd P/E (NTM)-3.68
  • EBITDA (TTM)-39.144M
  • ROE (TTM)-909.03%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-120.18%

EVENTS

  • Earnings Date03/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galectin Therapeutics Inc

 

Profile

MORE
Galectin Therapeutics Inc. is a clinical-stage biotechnology company. The Company is engaged in drug research and development to create new therapies for fibrotic disease, cancer and selected other diseases. The Company’s drug candidates are based on its method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. The Company’s product candidates include galectin-3 inhibitor, which is a belapectin and GM-CT-01. The Company’s lead drug...
Richard Uihlein
Independent Chairman of the Board
Joel Lewis CPA
President, Chief Executive Officer, Director
Jack Callicutt CPA
Chief Financial Officer
Address
SUITE 240
4960 PEACHTREE INDUSTRIAL BOULEVARD
Norcross, GA
30071
United States

Top Peers

SYMBOLLASTCHG%CHG
ACHV
Achieve Life Sciences Inc
4.54UNCHUNCH
PDSB
PDS Biotechnology Corp
3.96UNCHUNCH
NVCT
Nuvectis Pharma Inc
8.20UNCHUNCH
PRAX
Praxis Precision Medicines Inc
61.02UNCHUNCH
ACRV
Acrivon Therapeutics Inc
7.15UNCHUNCH